<DOC>
	<DOCNO>NCT01863147</DOCNO>
	<brief_summary>Cardiovascular complication account high mortality type 2 diabetic patient , mainly due coronary artery disease ( CAD ) .Left ventricular hypertrophy ( LVH ) widespread type 2 diabetic patient CAD , even absence hypertension .It strong predictor cardiovascular event all-cause mortality . Sitagliptin , inhibitor dipeptidyl peptidase-4 ( DPP-4 ) , may regress leave ventricular mass ( LVM ) newly diagnose type 2 diabetic patient CAD .</brief_summary>
	<brief_title>Sitagliptin Reduces Left Ventricular Mass Normotensive Type 2 Diabetic Patients With Coronary Artery Disease</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Acarbose</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patients level hemoglobin A1c ( HbA1c ) &gt; 7.0 % . They also either angiographically document coronary artery disease previous history myocardial infarction . In addition , also require office BP &lt; 135/85 mm Hg presence LVH echocardiography ( American Society Echocardiography criterion LVM index [ LVMI ] &gt; 115 g/m2 men &gt; 95 g/m2 woman ) . Patients exclude currently prescribe glucagonlike peptide ( GLP ) 1 analogue DPP4 inhibitor glucosidase inhibitor antihypertensive drug ( include bblockers ) , diabetes medication , estrogen supplement , thyroxine , diuretic , hypolipidemic drug . They also exclude renal liver dysfunction , heart failure , malignancy , unable give inform consent . Patients contraindication cardiac magnetic resonance ( CMR ) ( pacemaker , claustrophobia ) also exclude , pregnant lactate woman .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Type 2 diabetes</keyword>
	<keyword>leave ventricular mass</keyword>
	<keyword>inhibitor dipeptidyl peptidase-4</keyword>
</DOC>